+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plantibodies - Global Strategic Business Report

  • PDF Icon

    Report

  • 486 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6106188
The global market for Plantibodies was valued at US$53.2 Million in 2025 and is projected to reach US$89.3 Million by 2032, growing at a CAGR of 7.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Plantibodies Market - Key Trends & Drivers Summarized

What Are Plantibodies and Why Are They Attracting Biopharmaceutical Interest?

Plantibodies are antibodies produced in genetically engineered plants through molecular farming. They function similarly to mammalian-derived monoclonal antibodies but are synthesized using plant expression systems such as tobacco, corn, rice, or barley. These plant-based antibodies offer an alternative route to traditional biopharmaceutical manufacturing, particularly for vaccines, therapeutics, and diagnostic agents.

The concept offers several advantages including lower production costs, reduced risk of contamination with human pathogens, and scalable agriculture-based manufacturing. Plantibodies are being explored for the treatment of infectious diseases, cancer, autoimmune conditions, and as components in diagnostic kits. Their relevance grew with increasing demand for rapid and flexible production platforms, especially during global health emergencies.

How Is the Technology Behind Plantibody Production Evolving?

Plantibody production involves inserting antibody-encoding genes into plant cells using techniques like Agrobacterium-mediated transformation or viral vectors. These transgenic plants then produce the desired antibodies in their leaves or seeds. The harvested material is processed and purified to extract functional antibodies. Advances in plant expression vectors, glycosylation control, and downstream purification have improved yield and biological equivalence to human antibodies.

Recent innovations in transient expression systems using plant viral vectors allow rapid production cycles and adaptability to emerging disease targets. Improvements in plant cell culture, containment farming, and molecular design have further enabled consistent performance across batches. Glycoengineering techniques are being used to humanize plant-derived antibodies for improved efficacy and reduced immunogenicity.

Where Are Applications Expanding and Who Is Using Plantibodies?

Research and early-stage clinical studies are evaluating plantibodies for conditions such as Ebola, Zika, COVID-19, and certain cancers. Several biotechnology companies and public health institutions have initiated trials and pilot production programs using Nicotiana benthamiana and other model plants. Plantibodies are also being explored in veterinary medicine, food safety diagnostics, and environmental biosensing.

Pharmaceutical producers are increasingly considering plant-based systems for large-scale, cost-sensitive antibody production. As biosimilars and novel therapeutics become more prominent, the demand for flexible, scalable, and biosafe manufacturing alternatives is growing. Diagnostic kit developers are using plantibodies to create rapid, stable, and transportable testing solutions, particularly for use in low-resource settings.

Growth in the Plantibodies market is driven by several factors

Growth in the plantibodies market is driven by increasing need for cost-effective biotherapeutics, improved genetic engineering of plant expression systems, and growing demand for rapid antibody production in response to emerging diseases. Expansion of transient expression techniques, improved downstream processing, and the rise of plant-based biosafety profiles are supporting adoption.

Application in global health diagnostics, interest in molecular farming for pandemic preparedness, and partnerships between biotech firms and agriculture researchers are accelerating development. Use in point-of-care testing, veterinary therapeutics, and passive immunization strategies also contributes to market potential. As regulatory frameworks evolve to support plant-based biologics, plantibodies are positioned to gain greater acceptance in pharmaceutical pipelines and global health strategies.

Report Scope

The report analyzes the Plantibodies market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Other Transgenic Crops); Technique (Conventional Method Technique, Tissue Culture Technique, Breeding & Sexual Crossing Technique, Transgenic Seeds Technique, Other Techniques); Application (Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Tobacco segment, which is expected to reach US$27.7 Million by 2032 with a CAGR of a 9.6%. The Legumes segment is also set to grow at 5.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $14.5 Million in 2025, and China, forecasted to grow at an impressive 12.0% CAGR to reach $19.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Plantibodies Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Plantibodies Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Plantibodies Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Agrisera AB, Biolex Therapeutics (Synthon), Fraunhofer IME, Greenovation Biotech GmbH, IBIO, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Plantibodies market report include:

  • Agrisera AB
  • Biolex Therapeutics (Synthon)
  • Fraunhofer IME
  • Greenovation Biotech GmbH
  • IBIO, Inc.
  • Icon Genetics (Nomad Bioscience)
  • Kentucky BioProcessing Inc.
  • Leaf Expression Systems
  • Mapp Biopharmaceutical, Inc.
  • Medicago Inc.
  • Morphosys AG
  • Planet Biotechnology Inc.
  • PlantForm Corporation
  • PlantiBodies (startup)
  • Protalix BioTherapeutics Inc.
  • Qualcomm of plantibodies?** Ventria Bioscience Inc.
  • Pfizer Inc.
  • ZEA Biosciences
  • Biocon Limited
  • iVitria / Ventria Affiliates**

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Plasma Apheresis Machines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Plasma-Derived Therapies Throws the Spotlight On Apheresis Infrastructure Expansion
  • Growth in Immunoglobulin and Albumin Demand Drives Need for Advanced Apheresis Machines
  • Increased Focus on Rare Disease Treatment Fuels Adoption of Automated Plasma Collection Platforms
  • Technological Advancements in Membrane and Centrifugal Separation Enhance Efficiency and Throughput
  • Expansion of Blood Component Therapy in Oncology and Neurology Propels Use of Plasma Apheresis Systems
  • Global Growth in Plasma Donation Programs Accelerates Investment in Mobile and Fixed Apheresis Units
  • Increased Regulatory Scrutiny on Plasma Collection Protocols Spurs Equipment Standardization
  • Integration of Touchless Interfaces and Real-Time Monitoring Enhances Donor Safety and Workflow Compliance
  • Strategic Partnerships Between Blood Centers and Device OEMs Boost Access to Apheresis Technology
  • Market Shift Toward Patient-Centric Therapies Supports Expansion of Therapeutic Apheresis Machines
  • Investment in Compact and Portable Platforms Enables Use in Rural and Mobile Settings
  • Rising Incidence of Autoimmune and Coagulation Disorders Strengthens Clinical Apheresis Applications
  • Increased Cross-Border Plasma Supply Agreements Drive Global Equipment Standardization
  • Integration of AI and Predictive Maintenance Tools Enhances Operational Reliability in High-Volume Centers
  • Growing Use of Apheresis in COVID and Post-COVID Therapy Trials Expands Procedure Adoption
  • Public-Private Partnerships in National Blood Services Encourage Procurement of Next-Gen Systems
  • Development of Multi-Component Collection Systems Increases ROI for Blood Banks
  • Emphasis on Closed-System and Low Contamination Risk Designs Boosts Donor Confidence
  • Workforce Training and Certification Initiatives Expand Apheresis Competency Across Regions
  • Device Reimbursement and Procedure Billing Advances Strengthen Market Access in Developed Countries
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Plasma Apheresis Machines Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Plasma Apheresis Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Plasma Apheresis Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Plasma Collection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Plasma Collection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Plasma Collection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Multi-Component Collection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Multi-Component Collection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Multi-Component Collection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Extracorporeal Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Extracorporeal Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Extracorporeal Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Plasma Donation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Plasma Donation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Plasma Donation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 18: USA Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: USA 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 20: USA Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 21: USA Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: USA 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 24: Canada Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: Canada 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 26: Canada Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: Canada Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: Canada 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
JAPAN
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 30: Japan Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: Japan 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 32: Japan Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: Japan Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: Japan 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
CHINA
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 35: China Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 36: China Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: China 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 38: China Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: China Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: China 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
EUROPE
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 41: Europe Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 42: Europe Historic Review for Plasma Apheresis Machines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: Europe 13-Year Perspective for Plasma Apheresis Machines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 44: Europe Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: Europe Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: Europe 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 47: Europe Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 48: Europe Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: Europe 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
FRANCE
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 50: France Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 51: France Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: France 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 53: France Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 54: France Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: France 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
GERMANY
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 56: Germany Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: Germany Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: Germany 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 59: Germany Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 60: Germany Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 61: Germany 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
ITALY
  • Table 62: Italy Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: Italy Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 64: Italy 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 65: Italy Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 66: Italy Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 67: Italy 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 68: UK Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 69: UK Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 70: UK 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 71: UK Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 72: UK Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 73: UK 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
SPAIN
  • Table 74: Spain Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 75: Spain Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 76: Spain 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 77: Spain Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 78: Spain Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 79: Spain 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
RUSSIA
  • Table 80: Russia Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 81: Russia Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 82: Russia 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 83: Russia Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 84: Russia Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 85: Russia 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 87: Rest of Europe Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 88: Rest of Europe 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 90: Rest of Europe Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 91: Rest of Europe 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 93: Asia-Pacific Historic Review for Plasma Apheresis Machines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 94: Asia-Pacific 13-Year Perspective for Plasma Apheresis Machines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Plasma Apheresis Machines by Product Type - Plasma Collection System and Multi-Component Collection System Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 97: Asia-Pacific 13-Year Perspective for Plasma Apheresis Machines by Product Type - Percentage Breakdown of Value Sales for Plasma Collection System and Multi-Component Collection System for the Years 2020, 2026 & 2032
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Plasma Apheresis Machines by Application - Extracorporeal Therapy Application and Plasma Donation Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 100: Asia-Pacific 13-Year Perspective for Plasma Apheresis Machines by Application - Percentage Breakdown of Value Sales for Extracorporeal Therapy Application and Plasma Donation Application for the Years 2020, 2026 & 2032
AUSTRALIA
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Plasma Apheresis Machines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agrisera AB
  • Biolex Therapeutics (Synthon)
  • Fraunhofer IME
  • Greenovation Biotech GmbH
  • IBIO, Inc.
  • Icon Genetics (Nomad Bioscience)
  • Kentucky BioProcessing Inc.
  • Leaf Expression Systems
  • Mapp Biopharmaceutical, Inc.
  • Medicago Inc.
  • Morphosys AG
  • Planet Biotechnology Inc.
  • PlantForm Corporation
  • PlantiBodies (startup)
  • Protalix BioTherapeutics Inc.
  • Qualcomm of plantibodies?** Ventria Bioscience Inc.
  • Pfizer Inc.
  • ZEA Biosciences
  • Biocon Limited
  • iVitria / Ventria Affiliates**

Table Information